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Many emerging RNA viruses of public health concern have recently been detected in bats. However, the dynamics of these
viruses in natural bat colonies is presently unknown. Consequently, prediction of the spread of these viruses and the
establishment of appropriate control measures are hindered by a lack of information. To this aim, we collected
epidemiological, virological and ecological data during a twelve-year longitudinal study in two colonies of insectivorous
bats (Myotis myotis) located in Spain and infected by the most common bat lyssavirus found in Europe, the European bat
lyssavirus subtype 1 (EBLV-1). This active survey demonstrates that cyclic lyssavirus infections occurred with periodic
oscillations in the number of susceptible, immune and infected bats. Persistence of immunity for more than one year was
detected in some individuals. These data were further used to feed models to analyze the temporal dynamics of EBLV-1 and
the survival rate of bats. According to these models, the infection is characterized by a predicted low basic reproductive rate
(R0=1.706) and a short infectious period (D=5.1 days). In contrast to observations in most non-flying animals infected with
rabies, the survival model shows no variation in mortality after EBLV-1 infection of M. myotis. These findings have considerable
public health implications in terms of management of colonies where lyssavirus-positive bats have been recorded and confirm
the potential risk of rabies transmission to humans. A greater understanding of the dynamics of lyssavirus in bat colonies also
provides a model to study how bats contribute to the maintenance and transmission of other viruses of public health concern.
Citation: Amengual B, Bourhy H, Lo ´pez-Roig M, Serra-Cobo J (2007) Temporal Dynamics of European Bat Lyssavirus Type 1 and Survival of Myotis
myotis Bats in Natural Colonies. PLoS ONE 2(6): e566. doi:10.1371/journal.pone.0000566
INTRODUCTION
In the last ten years, many emerging RNA viruses have been
detected in bat tissues [1]. These findings highlight the role of bats
in the maintenance and transmission of viruses of public health
concern. However, the way bats maintain and transmit these
viruses is currently unknown. The same is true for Lyssavirus,
viruses causing rabies in humans, for which bats are primary
reservoirs on all inhabited continents [2]. Six of the seven Lyssavirus
genotypes described to date infect bats. In Europe, two genotypes
of Lyssavirus, European bat Lyssavirus types 1 and 2 (EBLV-1 and
EBLV-2), circulate among several bat species [3–8,]. Numerous
bats are found infected each year (http://www.who-rabies-
bulletin.org) and the serotine bat (Eptesicus serotinus) appears to be
the main victim of EBLV-1 infections in several European
countries, according to data collected by passive surveillance
[3,7,9]. These viruses can also cause a fatal illness, indistinguish-
able from classic rabies, in non-flying mammal species, including
humans [3,10–13]. Therefore, bat rabies is a public health
concern in Europe. However, the epidemiology and the
pathogenicity of EBLV in bats are still unknown. In particular,
little data are available on the spatio-temporal dynamics of the
infection and how this virus influences the mortality rate in bat
colonies [5]. Studies addressing these issues require large
databases, collected over the years, to monitor and assess local
trends of rabies dynamics within a host population. These data are
available for a limited number of mammal species [14–17] but are
rare in bats [18,8]. Misunderstanding about the role of bats as
reservoirs and vectors of lyssaviruses have sometimes led to efforts
to extirpate bat populations and to indiscriminately reduce these
colonies, in spite of being protected species in many countries [92/
43 and 97/62 EU Directives, 19,20].
Six European insectivorous bat species (E. serotinus, Myotis myotis,
Myotis nattererii, Miniopterus schreibersii, Rhinolophus ferrumequinum and
Tadarida teniotis) were shown to be infected in Spain by EBLV-1
through active survey [6,18]. Here we have focused on M. myotis,
which has a wide distribution throughout Europe, mainly in the
south and center ofthecontinent [21].Weprovidethe first reporton
the temporal dynamics of lyssavirus and survival bat in a natural
colony based on a long term (12 years) longitudinal cross-sectional
study of the prevalence of EBLV-1 neutralizing antibodies and
EBLV-1 RNA in samples of that species. We also estimate, for the
first time, the mortality rate in M. myotis before and after infection by
EBLV-1 and describe the epidemiological characteristics of EBLV-1
infection in colonies of the same species by means of a simple
temporal dynamic model, which is further validated by data.
RESULTS
Ecology of M. myotis
Analysis of the cytochrome b gene demonstrated that the captured
bats belonged to the species M. myotis (data not shown). Refuge 1
shelters a breeding colony of 212 (95% confidence interval [CI],
162–300) M. myotis (referred to herein as colony 1). They reach the
cave in mid-April each year and begin to leave the cave at the
beginning of August. Refuge 2 shelters a breeding colony of 591
(95% CI, 377-804) bats from spring to fall (referred to herein as
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of M. myotis between these 2 refuges, which are 35 km apart
(Table S1).
Fluctuation in the percentage of seropositive bats
Neutralizing antibodies revealed a high frequency of exposure
(36.24%, n=643) to EBLV-1 in Myotis bats, with some differences
between colonies. The seroprevalence rate between adults and
juveniles and between males and females was not significantly
different in these colonies. No significant differences in the
percentage of seropositive bats was observed in colony 1 (Chi-
square X
2=6.55, df=9, p.0.5) during the study period (1995-
2005) (Figure 1A). Therefore, this colony was considered at
equilibrium and the average percentage of susceptible bats
obtained during this period (58.62%, 95% CI, 51.99%–65.25%)
was used to calculate the basic reproductive rate (R0=1.706, 95%
CI, 1.533 – 1.923).
In contrast, significant inter-annual variations inthe percentage of
seropositive bats were observed in colony 2 (Chi-square X
2=69.56,
df=9, p.0.000.1; Table 1). Four peaks in seropositive animals were
identified from 1995 to 2006: 1995–1996 (X
2=18.92, p,0.001);
2000–2002 (X
2=12.57,p,0.001); 2003–2004 (X
2=4.03, p,0.05);
2005–2006 (X
2=7.33, p,0.001) (Figure 1B).
The re-sampling of bats (2 to 4 times) at intervals between 1 and
8 years allowed us to follow the seroneutralization titer of 46
individuals over the years (Table 2). Seven individuals were
captured and analyzed more than twice at intervals of one or
several years. One bat was even analyzed four times between 1996
and 2004. This monitoring demonstrated that anti-EBLV-1
antibodies remained detectable in some M. myotis for at least one
year after seroconversion. Nineteen of these 46 bats show positive
antibody titers becoming negative in the following recapture
sessions after various intervals in years. This indicates that these
bats survive at least several years after their seroconversion.
Presence of EBLV-1 RNA in M. myotis
Dead bats (n=17) were collected and analyzed simultaneously by
FAT and by nRT-PCR. The FAT results were all negative. In
contrast, 2 M. myotis collected in refuge 2, in particular the brain of
one and the heart and tongue of the other were positive by nRT-
PCR.
The blood clots were also analyzed by nRT-PCR and gave
3.68% (n=136) and 5.17% (n=290) of positive reactions in
colonies 1 and 2, respectively (Table 1). nRT-PCR performed on
positive tissues without previous reverse transcription gave
negative results. Two of these positive samples (01076, 01077)
were further amplified on a larger region of the N gene (Acc. Nb
EF577260 and EF577261, respectively), and two of them (01077,
02085) were also amplified by nRT-PCR using primers targeting
the glycoprotein gene (Acc. Nb EF577262 and EF577263,
respectively). A comparative analysis of all the N 122bp-long
sequences amplified (EF187828-EF187847 and EF207412) in-
dicates that the sequences obtained during this study grouped with
previously described EBLV-1 [4]. The percentage of divergence
was calculated by comparison with 4 different EBLV-1 isolates. It
ranges from 0 to 4.9% with a French and a Dutch EBLV-1a
isolates (respectively 03002FRA and 9366HOL) and from 1.6 to
4.1 % with two Spanish EBLV-1b isolates (94285SPA and
9483SPA). Conversely this score was higher (from 20.5 to 23%)
with a Duvenhage isolate (86132SA) as well as with two EBLV-2
isolates 9018HOL and 9007FIN (from 23 to 27.9%).
Of all the blood samples analyzed by both nRT-PCR and
seroneutralization (n=429), only two were confirmed positive by
both techniques (X
2=8.91, p,0.01) (Figure 1; Table 1). This result
demonstrates the value of this simple sampling technique as
a complementary indicator to seroneutralization of EBLV-1
infection in a bat colony.
Survival of M. myotis
The apparent survival rate of colony 1 was calculated from 93 M.
myotis captured from 2001 to 2006. Among the set of candidate
models (Table S2), the best model showed no evidence of sex and
time dependence in survival rate (W=0.719, 95% CI, 0.407–0.905).
From 2000 to 2006, 799 M. myotis were captured in colony 2. The
best model (Table S2) also showed a constant survival rate
(W=0.708, 95% CI, 0.637–0.769) despite evidence of virus
infections, as demonstrated by temporal variations of the serocon-
version rate observed in this colony and the RT-PCR results. This
observation indicates that the mortality rate was not modified by
recurrentepidemiccycles and that the mortality induced byEBLV-1
infection, A, could be considered negligible in our analysis. Survival
rates of colonies 1 and 2 were not significantly different.
Temporal dynamics of EBLV-1 infection
The temporal pattern of EBLV-1 infection was determined by using
adynamicmodel[14](FigureS1),themortalityrate(m=0.281,95%
Figure 1. Temporal Variation of the Percentage of Sera and Blood
Clot Positives in Bat colonies. Percentage of seropositive (black
symbols) and blood clot positive (red symbols) bats observed in M.
myotis colonies 1 (A) and 2 (B) (95% confidence interval shown).
doi:10.1371/journal.pone.0000566.g001
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during the longitudinal study (R0=1.706, and recovery rate,
v=0.719, 95% CI, 0.407–0.905). The predicted average duration
of infectiousness was D = 5.077, 95% CI, 4.033 – 8.968.
The model shows that after the initial introduction of EBLV-1
in the susceptible bat population, seroprevalence tends to oscillate
following periods and amplitudes that diminish year after year
until they reach the equilibrium. The results obtained from colony
1 indicate that it is in the final phase of the model and, therefore,
the colony is near the equilibrium. However, in colony 2, the
oscillations observed in the number of seropositive bats indicate
that the colony is in the initial phase of the model (Figure 1 and 2).
This analysis proves that there is a good agreement between the
predicted and the observed values.
DISCUSSION
Bats are important reservoir hosts of RNA viruses, including
lyssaviruses, which can cross the species barrier to infect humans
and other domestic and wild non-flying mammals [1]. In Europe,
bat handlers and those entering bat habitats have been provided
with guidelines to avoid exposure to lyssaviruses that bats may
harbor [22]. These protective measures include rabies vaccina-
tions, protective personal equipment and post-exposure rabies
prophylaxis or booster doses of vaccination in case of exposure.
However, the policy concerning the maintenance of colonies in
buildings and caves open to the public, where rabies-positive bats
have been recorded, relies only on advice of experts and is still
controversial. To provide epidemiologists and public health
officials with data to effectively implement public health measures
regarding the conservation of bat populations, we undertook a 12-
year field study to identify the temporal dynamics of EBLV-1 in
coloniesofM.myotisbatsbycombiningmultidisciplinaryapproaches.
Data collected were used to predict the epidemiological character-
istics of EBLV-1infection inM. myotis by means of a simple temporal
dynamic model and to estimate the mortality rate.
In nature, the spatial structure of bat populations is variable and
may influence the dynamics of infection. Some gregarious bat
species have a metapopulation structure consisting of spatial
discrete subpopulations and seasonal interaction [1]. As demon-
strated by capture-recapture data, the insectivorous bat colonies
we studied showed limited exchange and could therefore be
considered as spatial discrete subpopulations of a few hundred
individuals. To maintain its circulation over the time in such
populations, the virus-host relationships should probably follow
some constraints in terms of mortality rate, development of
immunity and number of susceptible bats.
The significant fluctuations in the percentage of seropositive
bats observed in colony 2 are indicative of several different
episodes of EBLV-1 infection occurring in M. myotis colony during
the time of study. These different episodes of EBLV-1 infection did
not modify significantly the survival rate of M. myotis bats. None of
the bats captured (included all the sero- and nRT-PCR-positive)
displayed modified behavior that could be related to rabies.
Furthermore, 19 bats were shown to survive at least one year after
the characterization of EBLV-1-neutralizing antibodies in their
serum. These data provide the first evidence that mortality of M.
myotis in their natural environment does not increase significantly
after episodes of EBLV-1 infection. Therefore, our observations
support survival in M. myotis after EBLV-1 , as suggested for some
other bat species maintained in captivity [23–25] and more
recently for E. serotinus, which were found to survive for a long
period after EBLV-1 detection in their saliva [8]. Further studies
will probably be needed to evaluate more precisely the survival
rate of bats after EBLV-1 infection. However, our observation
already contrasts with findings in natural conditions in most wild
non-flying carnivores [16–17] and in other bat species [7,26].
Therefore, the evaluation of the risk of transmission of lyssavirus to
humans cannot be determined on the basis of observations of
abnormal mortality in bat colonies.
Rabies infection in non-flying animals is the paradigm for
studies of wildlife disease waves [16,27,28]. Here we established
that EBLV-1 infection in bats follows the same rule. The
epidemiological model used [14] is based on human infections
and, therefore, it is used as an approach. However, it explains the
patterns that follow the lyssavirus infection observed in Myotis
myotis. Observed and predicted (given by the model) data
concerning the variation of percentage of seropositive M. myotis
are concordant. Lyssavirus infection in M. myotis is characterized by
a high degree of bat immunity after circulation of the virus. This
high percentage of seropositive bats after infection is indicative of
efficient virus transmission between individuals and rapid
circulation of the virus in the colony. These findings are not
surprising in a gregarious bat species such as M. myotis in which
a high contact rate between individuals is facilitated in the roost,
where bats are concentrated in less than one square meter. After
the initial introduction of EBLV-1 into a susceptible bat
population, seroprevalence to this virus tends to oscillate (as
observed in colony 2); the amplitude of the oscillations gradually
Table 1. Results from serologic and antigenic analyses in M. myotis.
..................................................................................................................................................
Locality 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 TOTAL
Colony 1 A/B 7/21 7/32 3/12 3/7 5/28 0/6 5/17 5/17 8/28 9/21 5/19 nd 57/208
X6SD 122645 2076159 2186136 4126454 106661 NA- 65640 68632 1596125 67631 81668 nd
Range 83–195 53–442 129–374 87–930 29–176 NA 56–126 36–117 36–334 36–107 35–190 nd
C/D nd nd nd nd 0/28 0/6 2/17 0/17 3/28 0/21 0/19 nd 5/136
E/F nd nd nd 0/2 0/4 nd nd nd nd nd nd nd 0/6
Colony 2 A/B 1/30 16/27 11/27 7/22 3/30 3/30 6/16 17/31 22/59 35/61 17/45 38/57 176/435
X6SD 90 3486237 1916225 7186657 78627 58642 37624 55617 87679 115681 62645 115647
Range NA 49–908 29–783 79–1677 47–95 29–107 31–94 39–123 36–348 36–370 29–146 35–177
C/D nd nd nd nd 0/30 6/29 0/16 2/32 4/38 3/43 0/45 0/57 15/290
E/F nd 0/2 nd nd 0/4 1/3 0/1 nd 1/1 nd nd nd 2/11
A, number of seropositive bats. B, number of bat sera analyzed. X, mean seroneutralization titer of positive sera. SD, standard deviation. C, number of positive blood
clots. D, number of blood clots analyzed. E, number of positive dead bats. F, number of dead bats analyzed. nd, not done, NA, non applicable.
doi:10.1371/journal.pone.0000566.t001
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PLoS ONE | www.plosone.org 3 June 2007 | Issue 6 | e566Table 2. Individual Serological Follow-up in Recaptured Bats.
..................................................................................................................................................
Locality Year1 S1 C1 Year2 S2 C2 Year3 S3 C3 Year4 S4 C4
Colony 1 2002 45.8 - 2003 85.8 -
2002 0 - 2005 189.8 -
2003 65 - 2004 52.7 - 2005 0 -
2003 0 - 2004 35.5 -
2004 35.5 - 2005 126.6 -
2004 0 - 2005 35.5 -
2004 106.6 - 2005 0 -
Colony 2 1996 0 nd 2002 62.6 - 2003 44.4 - 2004 0 -
1996 709 nd 2002 69.2 -
1997 0 nd 2001 35.5 -
1997 29.3 nd 2001 0 -
1997 783.2 nd 2001 35.5 -
1997 0 nd 2004 67 +
1998 79.5 nd 2003 0 - 2004 0 -
2000 29 - 2001 38.8 -
2000 0 - 2001 40.5 -
2000 0 - 2002 50.3 -
2000 39 - 2002 48.6 - 2003 38.7 -
2001 35.5 - 2003 105.3 -
2002 84.1 - 2003 0 -
2002 62.6 - 2003 71.1 -
2002 52.7 - 2003 0 -
2002 110.3 - 2003 349 -
2002 0 - 2004 85.8 -
2002 94.8 + 2004 35.5 -
2002 116.2 - 2004 107 - 2006 169 -
2002 81.4 - 2005 0 -
2002 44.3 - 2005 0 -
2003 106.6 - 2004 0 -
2003 106.6 - 2004 35.5 -
2003 46.8 - 2004 0 -
2003 87.9 - 2004 107 -
2003 38.7 - 2004 149 -
2003 84.1 - 2004 155 -
2003 281.4 - 2004 154 - 2005 0 -
2003 123.5 - 2004 116 - 2006 147 -
2003 56.2 - 2005 0 -
2003 348.4 - 2005 0 -
2004 370 - 2005 0 -
2004 35.5 - 2005 0 -
2004 41.9 - 2005 0 -
2004 140 - 2005 0 -
2004 38.7 - 2005 0 -
2004 35.5 - 2005 0 -
2004 65 - 2006 107 -
2004 107 - 2006 116 -
Each row corresponds to an individual analyzed several times at intervals of one year or more. Year1 corresponds to the first year of analysis and Year2, Year3, Year4
correspond to the following years of re-capture, re-sampling and re-analysis. S, Antibody titer in the serum. C, nRT-PCR results performed on the clot. RT-PCR on blood
clots were not done (nd) before 1999. -: negative results by nRT-PCR, +: positive results by nRT-PCR.
doi:10.1371/journal.pone.0000566.t002
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PLoS ONE | www.plosone.org 4 June 2007 | Issue 6 | e566decreases until a steady equilibrium is achieved, as observed in
colony 1. These fluctuations in seroprevalence are characteristic of
infections that induce long-lasting immunity [14,29]. Bats recover
from infection and develop a degree of immunological protection
to future infection. Recapture data and individual serological
follow-up show that this immunity can persist for more than one
year. The delay between the waves is then dependent on the rate
of inflow of susceptible bats into the colonies as a consequence of
new births, immigration of naı ¨ve animals from neighboring
colonies, and expiration of EBLV-1-specific immunity in pre-
viously infected animals. When a sufficient fraction of susceptible
individuals in the bat population is reached, the virus spreads
again if infected individuals join the colony.
Having determined that the model corroborates observed
features of the dynamics of EBLV-1 infection in M. myotis bats,
we used it as a basis to further study the local spread of infection.
This allowed us to predict, for the first time, the R0 of Lyssavirus in
an insectivorous bat colony. The R0 value obtained (R0=1.706)
was lower than those recorded for most human infectious diseases
[14]. The prediction of the average duration of infectiousness
(D=5.1 days) is also new. This predicted value is comparable to
those observed in experimental conditions in Eptesicus fuscus [30]
and in natural conditions in raccoons [31] and dogs [32–34] but
shorter than that recorded in foxes [35].
In summary, this study demonstrates cyclic EBLV-1 infection in
spatial discrete subpopulations of M. myotis in Spain with periodic
oscillations in the number of susceptible, immune and infected bats
without any significant increase in associated mortality. Immunity
persists in some of the bats for more than one year. The temporal
dynamic model predicted a low basic reproductive rate and a short
infectious period. These observations could be attributed to a long
establishment of the infection in this species and virus-host co-
evolution, as already indicated by the low rate of evolutionary
change in EBLV-1 and by the low viral growth rate in the bat
population [5]. These findings are highly significant for the
development of measures to protect humans from the risk of
lyssavirus infection from bats. It confirms the potential risk of rabies
transmission to humans. This study also highlights the importance of
the dynamics of infection due to local spread within the colony, as
compared to long-range spread. However, recurrent epidemics are
probably triggered by the exchange of infective bats between
colonies. Greater understanding of the spatio-temporal dynamics of
Lyssavirus infection in bats also provides useful information for
epidemiologists and public health officials to forecast the spread and
severityoffutureoutbreaksof(re)emergingvirusescirculatinginbats.
MATERIAL AND METHODS
Capture of bats and collection of specimens and data
Biological samples and information about the seasonal movements
of bats and virus circulation were obtained from two bat colonies
in the locations of Inca and Llucmajor on Mallorca (Balearic
Islands, Spain), in which EBLV-1 infection was previously
demonstrated [18]. All captured bats were sexed and banded on
the forearm to facilitate the monitoring of individual infection and
their movements between colonies. Bats were captured in colony 1
from 1995 to 2006 during the daytime by means of a net. In the
last year very few blood samples were collected and they have not
been considered. During the same period bats were captured in
colony 2 at night, when they left for foraging, by means of a net
that entirely covered the entrance of the cave. In both cases the
capture method was always carried out in the same way
throughout the study. The few bat carcasses analyzed during the
study correspond to bats found dead during the fieldworks and to
the very few which unfortunately died during handling. They were
stored at 280uC before analysis. Blood samples were taken from
all captured bats from colony 1 [18]. As for colony 2, the bats
captured during the night were kept into cotton bags. Further,
some of them were randomly sampled for blood analyses.
The sizes of the both colonies were calculated indirectly by the
capture-recapture technique. The trap sessions were carried out in
Figure 2. Temporal Pattern Model. Temporal pattern of the number of susceptible bats X(t) in M. myotis colonies, obtained by Anderson & May
(1991) model, using R0 = 1.706 and his 95% confidence interval.
doi:10.1371/journal.pone.0000566.g002
Spreading of Bat Lyssavirus
PLoS ONE | www.plosone.org 5 June 2007 | Issue 6 | e566spring over six- (2001–2006 for colony 1) and seven- (2000–2006
for colony 2) year periods respectively. The sizes of the colonies
were estimated using the Jolly-Seber methodology for open
population incorporated in the Mark program [36].
Laboratory investigations
Brain, pharynx-esophagus, larynx, lung, heart and tongue samples
were collected from dead bats [26]. Fluorescent antibody test (FAT)
was performed on brain tissue specimens using polyclonal
fluorescent isothiocyanate-labelled rabbit anti-rabies nucleocapsid
immunoglobulin G (Bio-Rad) [26]. Serum and blood clot collected
from captured bats were analyzed separately. Total RNA was
extracted from bloodclotsand organsand testedbynRT-PCRusing
specific primers (N60-N41, N62-N63) targeting the EBLV-1 nucleo-
protein gene [3,18]. Positive PCR products were further sequenced
and compared, as previously described [3,5]. As a confirmation
method, some of the positive RNA samples were further tested by
nRT-PCR using primers N127-N499 (59-CTGCCACATTGGT-
CTTATAG-39, position 479 to 499 of the N coding region of the
rabies virus genome), N60-N41, targeting a larger region of the
nucleoprotein gene [5]. Two positive RNA samples were also
amplified by nRT-PCR using primers G594 (59-TCCAGA-
GAATCCTAAACCCG-39, position 594 to 604 of the G coding
region of the rabies genome)-G1197 (59-GCTCAATGTGCTGC-
TGTAAC-39, position 1197 to 1207 of the G coding region of the
rabies genome), G641 (59-GCAAAGGAAAGAAAGCAACC-39,
position 604 to 641 of the G coding region of the rabies genome)-
G1165 (position 1165 to 1185 of the G coding region of the rabies
genome).ThetechniqueusedforthedetectionofEBLV-1antibodies
is an adaptation of the Rapid Fluorescent Focus Inhibition Test
(RFFIT) [18,37]. A constant dose of a previously titrated, cell culture
adapted EBLV-1 challenge virus 8918FRA was incubated with 3
folddilutionsoftheseratobetitrated.Afterincubationoftheserum/
virus mixtures, a suspension of BSR cells was added. After 24 hours
incubation, the cell monolayer was acetone-fixed and stained with
a fluorescent anti-nucleocapsid antibody (BioRad, Marnes-la-Co-
quette, France) to detect the presence of non-neutralized virus
(fluorescent foci). Titers are presented as an arithmetic mean of two
independentrepetitions.Serumsampleswithantibodytiters,27are
considered negative for EBLV-1 neutralizing antibodies.
The annual percentages of seroprevalence were compared by
a Chi-square test.
Analysis of the sequences
A comparative analysis was performed on a 122 bp sequence of the
lyssavirus nucleoprotein gene using clustalx 1.83.3 [38]. Sequences
of isolates (03002FRA, Acc. Nb. AY863381; 9366HOL, Acc. Nb.
AY863359; 94285ESP, Acc. Nb. AY963391; 9483ESP, Acc.
Nb. AY863390; 9018HOL, Acc. Nb. AY863403; 9007FIN, Acc.
Nb. AY863406) representative of EBLV-1 and EBLV-2 diversity [5]
wereselected for comparison.Duvenhage isolate86132SA (Acc. Nb.
AY996323) was also used for comparison.
We partially sequenced the gene of cytochrome b to confirm
that the captured animals belonged to M. myotis [39].
Survival rate
The apparent survival probabilities (W)o fM. myotis from colonies 1
and 2 were estimated over a six- (2001–2006) and seven- (2000–
2006) year period, respectively. Years previous to 2000 were
excluded from analysis since the capture-recapture method was
performed in a different way. The juvenile individuals were
excluded from analysis. Survival rate was modeled following the
capture-mark-recapture methodology [40], using the Mark pro-
gram [41]. Model selection method was used to find the most
parsimonious model from a set of candidate models [40] (Table
S2).
Temporal dynamics of EBLV-1 infection
Basic Reproductive Rate (R0) of the virus in M. myotis was
calculated using the equation R0=1/x*, where x* represents the
host population fraction that is susceptible at equilibrium [14].
The value of x* was estimated from serological data observed in
colony 1 from 1995 to 2005. The recovery rate (v) was calculated
for colony 1 by equations Nos. 6.4, 6.11, 6.12 [14]. The average
duration of infectiousness (D) was obtained using the equation
D=1/v.
A dynamic model with 3 categories was used to predict the
temporal pattern of EBLV-1 infection (Figure S1). The bat
population was divided into susceptible (X), infected (Y) and
immune (Z). Changes of percentages in categories were obtained
by feeding the model with the ecological and epidemiological data
collected and in particular the differential equations Nos. 6.1–6.4,
as proposed by Anderson and May [14]. The model was evaluated
using Maple v9.01 software.
SUPPORTING INFORMATION
Table S1 No. of Recaptured and Analyzed M. myotis in Colonies
1 and 2, 1996–2006.
aSuccessive analyses in the same individuals
were made at intervals of $1 year
Found at: doi:10.1371/journal.pone.0000566.s001 (0.03 MB
DOC)
Table S2 Modeling Survival Probabilities of M. myotis in
Colonies 1 and 2.
Found at: doi:10.1371/journal.pone.0000566.s002 (0.07 MB
DOC)
Figure S1 Diagram of the Flow of Hosts between Susceptible.
This diagram shows the dynamics of the interaction between
a directly transmitted virus and its host population. The host dies
at a per capita rate c. The infected host experiments an additional
death rate a, induced by virus infection and a seroconversion rate
u. The transmission coefficient b determines the rate at which new
infection arises as a consequence of mixing between susceptible
and infected individuals.
Found at: doi:10.1371/journal.pone.0000566.s003 (0.49 MB TIF)
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